Odronextamab (REGN1979)

Odronextamab · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Odronextamab (REGN1979), covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T [Phase 2]